32.73MMarket Cap-1.34P/E (TTM)
2.870High2.640Low2.32KVolume2.870Open2.770Pre Close6.49KTurnover0.06%Turnover RatioLossP/E (Static)11.82MShares5.00052wk High5.07P/B11.63MFloat Cap1.80052wk Low--Dividend TTM4.20MShs Float5.000Historical High--Div YieldTTM8.30%Amplitude1.800Historical Low2.793Avg Price1Lot Size
Medicus Pharma Stock Forum
📊⚡️📊
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
Monday, 2nd December at 7:30 am
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (TSXV: MDCX) ("Medicus" or the "Company") is pleased to announce an agreement with Swanielle Inc. ("Swanielle") to explore expansion of Phase 2 clinical study for treatment of Basal Cell Carcinoma (BCC) in the Asia-pacific region
.
Under the agreemen...
📊⚡️📊
📊⚡️📊
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
No comment yet